XERIS BIOPHARMA HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
XERIS BIOPHARMA HOLDINGS, INC. (XERS) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$49.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-02
- XERIS BIOPHARMA HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was -$49.00K.
- XERIS BIOPHARMA HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $142.00K, a 80.44% decline from fiscal 2022.
- XERIS BIOPHARMA HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $726.00K, a 59.19% decline from fiscal 2021.
- XERIS BIOPHARMA HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was $1.78M, a 150.56% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2025-12-31 | -$49.00K 10-K · filed 2026-03-02 |
| 2023-12-31 | $142.00K 10-K · filed 2024-03-06 |
| 2022-12-31 | $726.00K 10-K · filed 2024-03-06 |
| 2021-12-31 | $1.78M 10-K · filed 2024-03-06 |
| 2020-12-31 | $710.00K 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |